Development Description
Amendments to as-permitted development, located at the northwest corner of the existing IE8 Pharmaceutical Manufacturing Building, will consist of the demolition of the existing entrance and female changing room at ground floor and breakroom offices at mezzanine level, modifications to the existing IE8 building to facilitate the construction of a 5 storey extension (including mezzanine floor) as-permitted under planning register no. 21/6388, to be constructed in two phases with phase 1 complete. The proposed extension will include a range of support accommodation including new entrance, lobby, staff changing areas, WC facilities, canteen, office areas, electrical rooms, new stairs and lift and mechanical/electrical plantrooms areas, including rooftop plant. External works will include: modifications to existing ground levels to facilitate the proposed extension; alterations to existing elevations; modifications to the internal vehicle and pedestrian access roadways and all associated ancillary site development and drainage works. Proposed amendments will include an increase in floor area of the as-permitted extension from ground floor to roof level to extend the ground floor staging area and the provision of AHU plant platforms over, an increase in height of the as-permitted parapet level to accommodate roof plant screened enclosure, minor amendments to internal layouts and amendments to the external facades including revised fenestration designs. The development will be located on a site that currently operates under an Industrial Emissions (IE) License (P0009-04) under Part IV of the Environmental Protection Agency Act of 1992 (as amended for the protection of the Environment act 2003). The new development is on a site to which Chemicals Act (Control of Major Accidents Hazards involving Dangerous Substances) Regulations 2015 (S.I.209 of 2015) applies.